Lorenzo Botta - Search Results

Year	Number of Results
2008	1
2009	2
2010	2
2011	1
2013	2
2014	5
2015	6
2016	3
2017	8
2018	10
2019	5
2020	8
2021	8
2022	9
2023	6
2024	2

1

Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing Strategy.

Cesarini S, Vicenti I, Poggialini F, Filippi S, Mancin E, Fiaschi L, De Marchi E, Giammarino F, Vagaggini C, Bizzarri BM, Saladino R, Dreassi E, Zazzi M, Botta L. Cesarini S, et al. Among authors: botta l. Molecules. 2024 Mar 24;29(7):1452. doi: 10.3390/molecules29071452. Molecules. 2024. PMID: 38611732 Free PMC article.

2

An update on antibacterial AlkylGuanidino Ureas: Design of new derivatives, synergism with colistin and data analysis of the whole library.

Ardino C, Sannio F, Poli G, Galati S, Dreassi E, Botta L, Docquier JD, D'Agostino I. Ardino C, et al. Among authors: botta l. Eur J Med Chem. 2024 Apr 15;270:116362. doi: 10.1016/j.ejmech.2024.116362. Epub 2024 Mar 28. Eur J Med Chem. 2024. PMID: 38574637

3

Molecular Dynamics Investigations of Human DNA-Topoisomerase I Interacting with Novel Dewar Valence Photo-Adducts: Insights into Inhibitory Activity.

Di Martino J, Arcieri M, Madeddu F, Pieroni M, Carotenuto G, Bottoni P, Botta L, Castrignanò T, Gabellone S, Saladino R. Di Martino J, et al. Among authors: botta l. Int J Mol Sci. 2023 Dec 23;25(1):234. doi: 10.3390/ijms25010234. Int J Mol Sci. 2023. PMID: 38203410 Free PMC article.

4

Pseudorabies virus hijacks DDX3X, initiating an addictive "mad itch" and immune suppression, to facilitate viral spread.

Cronin SJF, Tejada MA, Song R, Laval K, Cikes D, Ji M, Brai A, Stadlmann J, Novatchikova M, Perlot T, Ali OH, Botta L, Decker T, Lazovic J, Hagelkruys A, Enquist L, Rao S, Koyuncu OO, Penninger JM. Cronin SJF, et al. Among authors: botta l. bioRxiv [Preprint]. 2023 May 9:2023.05.09.539956. doi: 10.1101/2023.05.09.539956. bioRxiv. 2023. PMID: 37214906 Free PMC article. Preprint.

5

Synthesis of Artesunic Acid-Coumarin Hybrids as Potential Antimelanoma Agents.

Zippilli C, Filippi S, Cesarini S, Bizzarri BM, Conigliaro P, De Marchi E, Botta L, Saladino R. Zippilli C, et al. Among authors: botta l. ACS Med Chem Lett. 2023 Apr 24;14(5):599-605. doi: 10.1021/acsmedchemlett.3c00019. eCollection 2023 May 11. ACS Med Chem Lett. 2023. PMID: 37197457

6

Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors.

Balestri LJI, Trivisani CI, Orofino F, Fiorucci D, Truglio GI, D'Agostino I, Poggialini F, Botta L, Docquier JD, Dreassi E. Balestri LJI, et al. Among authors: botta l. ACS Med Chem Lett. 2023 Mar 21;14(4):417-424. doi: 10.1021/acsmedchemlett.2c00472. eCollection 2023 Apr 13. ACS Med Chem Lett. 2023. PMID: 37077400 Free PMC article.

7

Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme.

Poggialini F, Vagaggini C, Brai A, Pasqualini C, Crespan E, Maga G, Perini C, Cabella N, Botta L, Musumeci F, Frosini M, Schenone S, Dreassi E. Poggialini F, et al. Among authors: botta l. Pharmaceutics. 2023 Jan 30;15(2):453. doi: 10.3390/pharmaceutics15020453. Pharmaceutics. 2023. PMID: 36839775 Free PMC article.

8

A Green Blue LED-Driven Two-Liquid-Phase One-Pot Procedure for the Synthesis of Estrogen-Related Quinol Prodrugs.

De Marchi E, Botta L, Bizzarri BM, Saladino R. De Marchi E, et al. Among authors: botta l. Molecules. 2022 Dec 16;27(24):8961. doi: 10.3390/molecules27248961. Molecules. 2022. PMID: 36558094 Free PMC article.

9

Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity.

Cesarini S, Vicenti I, Poggialini F, Secchi M, Giammarino F, Varasi I, Lodola C, Zazzi M, Dreassi E, Maga G, Botta L, Saladino R. Cesarini S, et al. Among authors: botta l. Molecules. 2022 Dec 12;27(24):8829. doi: 10.3390/molecules27248829. Molecules. 2022. PMID: 36557962 Free PMC article.

10

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of New Drugs against Human Topoisomerase I Receptor.

Madeddu F, Di Martino J, Pieroni M, Del Buono D, Bottoni P, Botta L, Castrignanò T, Saladino R. Madeddu F, et al. Among authors: botta l. Int J Mol Sci. 2022 Nov 24;23(23):14652. doi: 10.3390/ijms232314652. Int J Mol Sci. 2022. PMID: 36498979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year